Cargando…

Duchenne Muscular Dystrophy from Brain to Muscle: The Role of Brain Dystrophin Isoforms in Motor Functions

Brain function and its effect on motor performance in Duchenne muscular dystrophy (DMD) is an emerging concept. The present study explored how cumulative dystrophin isoform loss, age, and a corticosteroid treatment affect DMD motor outcomes. A total of 133 genetically confirmed DMD patients from Sri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wijekoon, Nalaka, Gonawala, Lakmal, Ratnayake, Pyara, Amaratunga, Dhammika, Hathout, Yetrib, Mohan, Chandra, Steinbusch, Harry W. M., Dalal, Ashwin, Hoffman, Eric P., de Silva, K. Ranil D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488491/ https://www.ncbi.nlm.nih.gov/pubmed/37685704 http://dx.doi.org/10.3390/jcm12175637

Ejemplares similares

Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology
por: Wijekoon, Nalaka, et al.
Publicado: (2023)

Gene therapy for selected neuromuscular and trinucleotide repeat disorders – An insight to subsume South Asia for multicenter clinical trials
por: Wijekoon, Nalaka, et al.
Publicado: (2023)

What We Fail to See in Neuro-Genetic Diseases: A Bird’s Eye View from the Developing World
por: Samaranayake, Navami, et al.
Publicado: (2020)

Investigating the role of dystrophin isoform deficiency in motor function in Duchenne muscular dystrophy
por: Chesshyre, Mary, et al.
Publicado: (2022)

Biopiracy: Abolish Corporate Hijacking of Indigenous Medicinal Entities
por: Imran, Yoonus, et al.
Publicado: (2021)

Therapeutic Implications of Some Natural Products for Neuroimmune Diseases: A Narrative of Clinical Studies Review
por: Wijeweera, Gayathri, et al.
Publicado: (2023)

Clinical utility of serum biomarkers in Duchenne muscular dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2016)

Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy
por: Ogundele, Michael, et al.
Publicado: (2021)

Influence of full-length dystrophin on brain volumes in mouse models of Duchenne muscular dystrophy
por: Kogelman, Bauke, et al.
Publicado: (2018)

Startle responses in Duchenne muscular dystrophy: a novel biomarker of brain dystrophin deficiency
por: Maresh, Kate, et al.
Publicado: (2022)

Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy
por: Naidoo, Michael, et al.
Publicado: (2019)

Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
por: Happi Mbakam, Cedric, et al.
Publicado: (2022)

Comparison of Serum Pharmacodynamic Biomarkers in Prednisone-Versus Deflazacort-Treated Duchenne Muscular Dystrophy Boys
por: Tawalbeh, Shefa, et al.
Publicado: (2020)

Complete restoration of multiple dystrophin isoforms in genetically corrected Duchenne muscular dystrophy patient–derived cardiomyocytes
por: Zatti, Susi, et al.
Publicado: (2014)

Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy
por: Doorenweerd, Nathalie, et al.
Publicado: (2017)

Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy
por: Kemaladewi, Dwi U, et al.
Publicado: (2011)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, Simon, et al.
Publicado: (2019)

The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene
por: Hoffman, Eric P.
Publicado: (2020)

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy
por: Frank, Diane E., et al.
Publicado: (2020)

Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies
por: Anand, Akshay, et al.
Publicado: (2015)

Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys
por: Dang, Utkarsh J, et al.
Publicado: (2020)

Intellectual Ability in the Duchenne Muscular Dystrophy and Dystrophin Gene Mutation Location
por: Milic Rasic, V, et al.
Publicado: (2015)

Systemic AAV Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy
por: Duan, Dongsheng
Publicado: (2018)

Author Correction: Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy
por: Doorenweerd, Nathalie, et al.
Publicado: (2018)

Mitochondria mediate cell membrane repair and contribute to Duchenne muscular dystrophy
por: Vila, Maria C, et al.
Publicado: (2017)

Dystrophin Gene Mutation Location and the Risk of Cognitive Impairment in Duchenne Muscular Dystrophy
por: Taylor, Peter J., et al.
Publicado: (2010)

Characterization of Dystrophin Deficient Rats: A New Model for Duchenne Muscular Dystrophy
por: Larcher, Thibaut, et al.
Publicado: (2014)

Deletion pattern in the dystrophin gene in Duchenne muscular dystrophy patients in northeast India
por: Basumatary, Lakshya J, et al.
Publicado: (2013)

Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches
por: Shimizu-Motohashi, Yuko, et al.
Publicado: (2019)

Restorative treatments of dystrophin expression in Duchenne muscular dystrophy: A systematic review
por: Pascual‐Morena, Carlos, et al.
Publicado: (2020)

Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy
por: Farrokhi, Vahid, et al.
Publicado: (2021)

Tandem Mass Tag-Based Serum Proteome Profiling for Biomarker Discovery in Young Duchenne Muscular Dystrophy Boys
por: Alayi, Tchilabalo D., et al.
Publicado: (2020)

Evaluation of exon-skipping strategies for Duchenne muscular dystrophy utilizing dystrophin-deficient zebrafish
por: Berger, Joachim, et al.
Publicado: (2011)

Dystrophin Dp116: A Yet to Be Investigated Product of the Duchenne Muscular Dystrophy Gene
por: Matsuo, Masafumi, et al.
Publicado: (2017)

Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy
por: Hathout, Yetrib, et al.
Publicado: (2019)

Utility of MLPA in mutation analysis and carrier detection for Duchenne muscular dystrophy
por: Verma, Prashant K., et al.
Publicado: (2012)

Systemic PPMO-mediated dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy
por: Gushchina, Liubov V., et al.
Publicado: (2022)

An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed
por: Smith, Bruce F., et al.
Publicado: (2010)

Full-length human dystrophin on human artificial chromosome compensates for mouse dystrophin deficiency in a Duchenne muscular dystrophy mouse model
por: Hiramuki, Yosuke, et al.
Publicado: (2023)

Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
por: Boca, Simina M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_525hr7873pfhmb0ur29pdihn9s